Ocugen Inc. amended its previous filing to include omitted exhibits related to a $30 million loan agreement with Avenue Capital Management, which will be used for working capital and matures on November 1, 2028, with a variable interest rate based on the prime rate plus 4.25%. Additionally, the company issued shares to the lenders as part of a subscription agreement.